Shensong Yangxin (SSYX) ameliorates disordered excitation transmission by suppressing cardiac collagen hyperplasia in rabbits with chronic myocardial infarction

详细信息    查看全文

• 作者：Song Dang 僿替/a> ; Cong-Xin Huang 黄从政/a>…
• 刊名：Journal of Huazhong University of Science and Technology [Medical Sciences]
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：36
• 期：2
• 页码：162-167
• 全文大小：3,555 KB
• 参考文献：1.Yu PJ, Cassiere HA, Kohn N, et al. Myocardial infarction classification on outcomes in nonemergent coronary artery bypass grafting. Ann Thorac Surg, 2015,100(5):1588–1593CrossRef PubMed
  2.Hayashi M, Shimizu W, Albert C M. The spectrum of epidemiology underlying sudden cardiac death. Circ Res, 2015,116(12):1887–1906CrossRef PubMed
  3.Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation, 2013,128(4):388–400CrossRef PubMed PubMedCentral
  4.Ringenberg J, Deo M, Filgueiras-Rama D, et al. Effects of fibrosis morphology on reentrant ventricular tachycardia inducibility and simulation fidelity in patient-derived models. Clin Med Insights Cardiol, 2014,8(Suppl 1):1–13CrossRef PubMed PubMedCentral
  5.Anderson ML, Peterson ED, Peng SA, et al. Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification: A report from NCDR. Circ Cardiovasc Qual Outcomes, 2013,6(6):708–715CrossRef PubMed
  6.Lu HR, Rohrbacher J, Vlaminckx E, et al. Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers. Br J Pharmacol, 2010,160(1):60–76CrossRef PubMed PubMedCentral
  7.Borowicz KK, Banach M. Antiarrhythmic drugs and epilepsy. Pharmacol Rep, 2014,66(4):545–551CrossRef PubMed
  8.Wu Y. Construction of the vessel-collateral theory and its guidance for prevention and treatment of vasculopathy. Front Med, 2011,5(2):118–122CrossRef PubMed
  9.Liu M, Zhao S, Wang Y, et al. Identification of multiple constituents in Chinese medicinal prescription Shensong Yangxin capsule by ultra-fast liquid chromatography combined with quadrupole time-of-flight mass spectrometry. J Chromatogr Sci, 2015,53(2):240–252CrossRef PubMed
  10.Liu Y, Li N, Jia Z, et al. Chinese medicine Shensong Yangxin is effective for patients with bradycardia: results of a randomized, double-blind, placebo-controlled multicenter trial. Evid Based Complement Alternat Med, 2014,2014(1): 605 714–605 714
  11.Zou JG, Zhang J, Jia ZH, et al. Evaluation of the traditional Chinese Medicine Shensong Yangxin capsule on treating premature ventricular contractions: a randomized, double-blind, controlled multicenter trial. Chin Med J (Engl), 2011,124(1):76–83
  12.Fujita M, Morimoto Y, Ishihara M, et al. A new rabbit model of myocardial infarction without endotracheal intubation. J Surg Res, 2004,116(1):124–128CrossRef PubMed
  13.Dhein S, Manicone N, Muller A, et al. A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study. Naunyn Schmiedebergs Arch Pharmacol, 1994,350(2):174–184PubMed
  14.Amino M, Yoshioka K, Tanabe T, et al. Heavy ion radiation up-regulates Cx43 and ameliorates arrhythmogenic substrates in hearts after myocardial infarction. Cardiovasc Res, 2006,72(3):412–421CrossRef PubMed
  15.Smaill BH, Zhao J, Trew ML. Three-dimensional impulse propagation in myocardium: arrhythmogenic mechanisms at the tissue level. Circ Res, 2013,112(5):834–848CrossRef PubMed
  16.Navarrete EG, Liang P, Lan F, et al. Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays. Circulation, 2013,128(11 Suppl 1):S3–S13CrossRef PubMed
  17.Kandel SM, Roth BJ. The mechanism of reflection type reentry: A simulation study. J Cardiovasc Electrophysiol, 2015,26(12):1370–1375CrossRef PubMed
  18.Mihic A, Cui Z, Wu J, et al. A Conductive polymer hydrogel supports cell electrical signaling and improves cardiac function after implantation into myocardial infarct. Circulation, 2015,132(8): 772–784CrossRef PubMed
  19.Majumder R, Nayak AR, Pandit R. Nonequilibrium arrhythmic states and transitions in a mathematical model for diffuse fibrosis in human cardiac tissue. PLoS One, 2012,7(10):e45040–e45040CrossRef PubMed PubMedCentral
  20.Tschabrunn CM, Roujol S, Nezafat R, et al. A swine model of infarct-related reentrant ventricular tachycardia: Electroanatomic, magnetic resonance, and histopathological characterization. Heart Rhythm, 2016,13(1):262–273CrossRef PubMed PubMedCentral
  21.Jenkins G. The role of proteases in transforming growth factor-beta activation. Int J Biochem Cell Biol, 2008, 40:1068–1078CrossRef PubMed
  22.Shen N, Li X, Zhou T, et al. Shensong Yangxin capsule prevents diabetic myocardial fibrosis by inhibiting TGF-beta1/Smad signaling. J Ethnopharmacol, 2014,157: 161–170CrossRef PubMed
  23.Shi T, Yao Z, Qin Z, et al. Identification of absorbed constituents and metabolites in rat plasma after oral administration of Shen-Song-Yang-Xin using ultra-performance liquid chromatography combined with quadrupole time-of-flight mass spectrometry. Biomed Chromatogr, 2015,29(9):1440–1452CrossRef PubMed
  
• 作者单位：Song Dang 党 松 (1) (2)
  Cong-Xin Huang 黄从新 (1) (2)
  Xi Wang 王 晞 (1) (2)
  Xin Wang 王 鑫 (1) (2)
  Juan Hu 胡 娟 (1) (2)
  He Huang 黄 鹤 (1) (2)
  
  1. Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China
  2. Cardiovascular Research Institute of Wuhan University, Wuhan, 430060, China
  
• 刊物主题：Medicine/Public Health, general;
• 出版者：Springer Berlin Heidelberg
• ISSN：1993-1352

文摘